View Author
level cholesterol plasma patient appslxps 1mut mice treatment adiponectin study expression activity protein appslxp brain lipid simvastatin effect lipase c 57bl mice lipoprotein rotation disease concentration hdl-c transfer type 2 diabetes subject triglycerides metabolism simvastatin 80 mg fasting month diabetes t 0901317 treatment syndrome ester atorvastatin baseline group plasma adiponectin levels signi ficantly signi value postprandial leucocyte cetp expression leucocyte t 0901317 wild-type mice alzheimer cholesteryl adiponectin levels 9 months hdl cholesterol 21 months appslxps 1mut uap patients pattern cetp tg mice amyloid atorvastatin treatment result liver table journal mouse heart control memory lipase activity postheparin plasma ± sem criteria netherland triglyceride hippocampu lpl activity cortex increase cetp mrna expression 1 m nacl serum
8 Most Recent Publications
|
Liver X receptor activation restores memory in aged AD mice without reducing amyloid
(Article)
Vanmierlo, T. Rutten, K. Prickaerts, J. Lütjohann, D. Mulder, M. Dederen, J. Bloks, V.W. Vark-van der Zee, L.C. van Kuipers, F. Kiliaan, A.J. Blokland, A. Sijbrands, E.J.G. Steinbusch, H. |
2011-07-01
|
|
Diagnostic Value of Rigid Body Rotation in Noncompaction Cardiomyopathy
(Article)
Dalen, B.M. van Caliskan, K. Soliman, O.I.I. Kauer, F. Zwaan, H.B. van der Vletter, W.B. Vark-van der Zee, L.C. van Cate, F.J. ten Geleijnse, M.L. |
2011-05-01
|
|
Alterations in brain cholesterol metabolism in the APPSLxPS1mut mouse, a model for Alzheimer's disease
(Article)
Vanmierlo, T. Bloks, V.W. Mulder, M. Vark-van der Zee, L.C. van Rutten, K. Kerksiek, A. Friedrichs, S. Sijbrands, E.J.G. Steinbusch, H.W. Kuipers, T.A.F. Lütjohann, D. |
2010-02-01
|
|
Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes.
(Article)
Hoek, M. van Tol, A. van Vark-van der Zee, L.C. van Jansen, H. Kastelein, J.J. Sijbrands, E.J.G. Dallinga-Thie, G.M. |
2009-01-01
|
|
The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients
(Article)
Hajer, G.R. Dallinga-Thie, G.M. Vark-van der Zee, L.C. van Visseren, F.L.J. |
2009-01-01
|
|
Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes
(Article)
Ye, D. Kraaijeveld, A.O. Hoogendoorn, P.C.W. Biessen, E.A.L. Berkel, Th.J.C. van Jukema, J.W. Eck, M. van Grauss, R.W. Willems, S.M. Vark-van der Zee, L.C. van Jager, S.C.A. de Jauhiainen, M. Kuivenhoven, J.A. Dallinga-Thie, G.M. Atsma, D.E. |
2008-12-01
|
|
Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: A randomized double blind crossover trial
(Article)
Hajer, G.R. Dallinga-Thie, G.M. Vark-van der Zee, L.C. van Olijhoek, J.K. Visseren, F.L.J. |
2008-12-01
|
|
Appraisal of hepatic lipase and lipoprotein lipase activities in mice
(Article)
Dallinga-Thie, G.M. Zonneveld-de Boer, A.J. Vark-van der Zee, L.C. van Haperen, R. van Gent, T. van Jansen, H. Crom, R. de Tol, A. van |
2007-12-01
|